News und Analysen
![3 (AI) Plays That Could Rocket Higher In Q3: https://www.marketbeat.com/logos/articles/med_20230703134906_chart-amd-732023.png](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBMDVFYXc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--bef634565f7ae3ce99e6655658cb878978cf277a/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/med_20230703134906_chart-amd-732023.png?locale=de)
3 (AI) Plays That Could Rocket Higher In Q3
AI spending is set to explode. The analysts can’t agree on the final figures but agree on one thing: the numbers will be huge. One industry, the grocery industry, if you can believe it, is
![3 (AI) Plays That Could Rocket Higher In Q3: https://www.marketbeat.com/logos/articles/med_20230703134906_chart-amd-732023.png](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBMDVFYXc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--bef634565f7ae3ce99e6655658cb878978cf277a/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/med_20230703134906_chart-amd-732023.png?locale=de)
3 (AI) Plays That Could Rocket Higher In Q3
AI spending is set to explode. The analysts can’t agree on the final figures but agree on one thing: the numbers will be huge. One industry, the grocery industry, if you can believe it, is
![3 (AI) Plays That Could Rocket Higher In Q3: https://www.marketbeat.com/logos/articles/med_20230703134906_chart-amd-732023.png](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBMDVFYXc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--bef634565f7ae3ce99e6655658cb878978cf277a/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/med_20230703134906_chart-amd-732023.png?locale=de)
3 (AI) Plays That Could Rocket Higher In Q3
AI spending is set to explode. The analysts can’t agree on the final figures but agree on one thing: the numbers will be huge. One industry, the grocery industry, if you can believe it, is
![EV Makers Deliver Big...What it Means for Their Stocks: https://www.marketbeat.com/logos/articles/med_20230705072345_ev-makers-deliver-big.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBMDFFYXc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--b217c8d5e36edd4190be3958905f8c7725c6ac14/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/med_20230705072345_ev-makers-deliver-big.jpg?locale=de)
EV Makers Deliver Big...What it Means for Their Stocks
Global vehicle electrification is going full speed ahead.
A fleet of electric vehicle (EV) manufacturers provided monthly and quarterly updates over the weekend that can be summed up in one word
![EV Makers Deliver Big...What it Means for Their Stocks: https://www.marketbeat.com/logos/articles/med_20230705072345_ev-makers-deliver-big.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBMDFFYXc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--b217c8d5e36edd4190be3958905f8c7725c6ac14/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/med_20230705072345_ev-makers-deliver-big.jpg?locale=de)
EV Makers Deliver Big...What it Means for Their Stocks
Global vehicle electrification is going full speed ahead.
A fleet of electric vehicle (EV) manufacturers provided monthly and quarterly updates over the weekend that can be summed up in one word
![Goldman Sachs Reportedly Mulling Apple Card Move To Amex: https://www.marketbeat.com/logos/articles/med_20230705071109_goldman-sachs-reportedly-mulling-apple-card-move-t.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBMHhFYXc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--feb0731ed8e945de549fb9339d3e1077436b635b/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/med_20230705071109_goldman-sachs-reportedly-mulling-apple-card-move-t.jpg?locale=de)
Goldman Sachs Reportedly Mulling Apple Card Move To Amex
The Goldman Sachs Group (NYSE: GS) is reportedly in talks with American Express Co. (NYSE: AXP) regarding its Apple Inc. (NASDAQ: AAPL) credit card and other consumer-focused products connected
![Goldman Sachs Reportedly Mulling Apple Card Move To Amex: https://www.marketbeat.com/logos/articles/med_20230705071109_goldman-sachs-reportedly-mulling-apple-card-move-t.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBMHhFYXc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--feb0731ed8e945de549fb9339d3e1077436b635b/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/med_20230705071109_goldman-sachs-reportedly-mulling-apple-card-move-t.jpg?locale=de)
Goldman Sachs Reportedly Mulling Apple Card Move To Amex
The Goldman Sachs Group (NYSE: GS) is reportedly in talks with American Express Co. (NYSE: AXP) regarding its Apple Inc. (NASDAQ: AAPL) credit card and other consumer-focused products connected
![Goldman Sachs Reportedly Mulling Apple Card Move To Amex: https://www.marketbeat.com/logos/articles/med_20230705071109_goldman-sachs-reportedly-mulling-apple-card-move-t.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBMHhFYXc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--feb0731ed8e945de549fb9339d3e1077436b635b/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/med_20230705071109_goldman-sachs-reportedly-mulling-apple-card-move-t.jpg?locale=de)
Goldman Sachs Reportedly Mulling Apple Card Move To Amex
The Goldman Sachs Group (NYSE: GS) is reportedly in talks with American Express Co. (NYSE: AXP) regarding its Apple Inc. (NASDAQ: AAPL) credit card and other consumer-focused products connected
![Goldman Sachs Reportedly Mulling Apple Card Move To Amex: https://www.marketbeat.com/logos/articles/med_20230705071109_goldman-sachs-reportedly-mulling-apple-card-move-t.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBMHhFYXc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--feb0731ed8e945de549fb9339d3e1077436b635b/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/med_20230705071109_goldman-sachs-reportedly-mulling-apple-card-move-t.jpg?locale=de)
Goldman Sachs Reportedly Mulling Apple Card Move To Amex
The Goldman Sachs Group (NYSE: GS) is reportedly in talks with American Express Co. (NYSE: AXP) regarding its Apple Inc. (NASDAQ: AAPL) credit card and other consumer-focused products connected
![Moderna kündigt weltweite Zulassungsanträge für seinen Impfstoff MRNA-1345 gegen das Respiratorische Synzytial-Virus (RSV) an: https://mms.businesswire.com/media/20210106005629/en/850492/5/KO_LOGO_%28002%29.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBOHJaVlE9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--3d915176f7535c860c4c3ceeeaf878c96c6a98a6/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/KO_LOGO_-28002-29.jpg?locale=de)
Moderna kündigt weltweite Zulassungsanträge für seinen Impfstoff MRNA-1345 gegen das Respiratorische Synzytial-Virus (RSV) an
- Moderna hat Zulassungsanträge für den RSV-Prüfimpfstoff mRNA-1345 bei der Europäischen Arzneimittelagentur, bei Swissmedic und bei der Therapeutic Goods Administration in
![Moderna Announces Global Regulatory Submissions for Its Respiratory Syncytial Virus (RSV) Vaccine, MRNA-1345: https://mms.businesswire.com/media/20210106005629/en/850492/5/KO_LOGO_%28002%29.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBOHJaVlE9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--3d915176f7535c860c4c3ceeeaf878c96c6a98a6/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/KO_LOGO_-28002-29.jpg?locale=de)
Moderna Announces Global Regulatory Submissions for Its Respiratory Syncytial Virus (RSV) Vaccine, MRNA-1345
- Moderna has submitted marketing authorization applications for the investigational RSV vaccine, mRNA-1345, with the European Medicines Agency, Swissmedic, and the Therapeutic Goods
![Dr. Reuter Investor Relations - Anlageklasse Wasser: Fünf Aktien, die Anleger auf dem Radar haben sollten: https://www.irw-press.at/prcom/images/messages/2023/71229/De.mem_Snapshot_Wasseraktien_13.Juni2023_final_.001.png](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBOFJEYXc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--fcc93ad9cfb5bcfde163ac8e1a1de5467e44593d/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/De.mem_Snapshot_Wasseraktien_13.Juni2023_final_.001.png?locale=de)
Dr. Reuter Investor Relations - Anlageklasse Wasser: Fünf Aktien, die Anleger auf dem Radar haben sollten
Wasser ist die essenzielle Ressource allen Lebens und ein kostbares Wirtschaftsgut. Zu kostbar, um es zu verschwenden. Der Markt für eine nachhaltige und effiziente Wasserwirtschaft ist
![Dr. Reuter Investor Relations - Anlageklasse Wasser: Fünf Aktien, die Anleger auf dem Radar haben sollten: https://www.irw-press.at/prcom/images/messages/2023/71229/De.mem_Snapshot_Wasseraktien_13.Juni2023_final_.001.png](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBOFJEYXc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--fcc93ad9cfb5bcfde163ac8e1a1de5467e44593d/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/De.mem_Snapshot_Wasseraktien_13.Juni2023_final_.001.png?locale=de)
Dr. Reuter Investor Relations - Anlageklasse Wasser: Fünf Aktien, die Anleger auf dem Radar haben sollten
Wasser ist die essenzielle Ressource allen Lebens und ein kostbares Wirtschaftsgut. Zu kostbar, um es zu verschwenden. Der Markt für eine nachhaltige und effiziente Wasserwirtschaft ist
![Eilt: Erstklassige Studienergebnisse im Kampf gegen Hautkrebs. Neuer 217% Biotech Hot Stock nach 3.296% mit BioNTech ($BNTX), 10.996% mit Pfizer ($PFE), 31.205% mit Amgen ($AMG) und 134.452% mit Biogen ($BIIB). Jetzt 217% mit Biotech Aktientip Vidac : https://www.irw-press.at/prcom/images/messages/2023/71224/AC_VidacPharma_050723.001.png](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBNzVEYXc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--e681713d74d225c9ff5e1cb9ac83ef3ff82c2797/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/AC_VidacPharma_050723.001.png?locale=de)
Eilt: Erstklassige Studienergebnisse im Kampf gegen Hautkrebs. Neuer 217% Biotech Hot Stock nach 3.296% mit BioNTech ($BNTX), 10.996% mit Pfizer ($PFE), 31.205% mit Amgen ($AMG) und 134.452% mit Biogen ($BIIB). Jetzt 217% mit Biotech Aktientip Vidac
Eilt: Erstklassige Studienergebnisse im Kampf gegen Hautkrebs. Neuer 217% Biotech Hot Stock nach 134.452% mit Biogen
05.07.23 08:17
London (www.aktiencheck.de, Anzeige)
![Eilt: Erstklassige Studienergebnisse im Kampf gegen Hautkrebs. Neuer 217% Biotech Hot Stock nach 3.296% mit BioNTech ($BNTX), 10.996% mit Pfizer ($PFE), 31.205% mit Amgen ($AMG) und 134.452% mit Biogen ($BIIB). Jetzt 217% mit Biotech Aktientip Vidac : https://www.irw-press.at/prcom/images/messages/2023/71224/AC_VidacPharma_050723.001.png](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBNzVEYXc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--e681713d74d225c9ff5e1cb9ac83ef3ff82c2797/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/AC_VidacPharma_050723.001.png?locale=de)
Eilt: Erstklassige Studienergebnisse im Kampf gegen Hautkrebs. Neuer 217% Biotech Hot Stock nach 3.296% mit BioNTech ($BNTX), 10.996% mit Pfizer ($PFE), 31.205% mit Amgen ($AMG) und 134.452% mit Biogen ($BIIB). Jetzt 217% mit Biotech Aktientip Vidac
Eilt: Erstklassige Studienergebnisse im Kampf gegen Hautkrebs. Neuer 217% Biotech Hot Stock nach 134.452% mit Biogen
05.07.23 08:17
London (www.aktiencheck.de, Anzeige)
![Eilt: Erstklassige Studienergebnisse im Kampf gegen Hautkrebs. Neuer 217% Biotech Hot Stock nach 3.296% mit BioNTech ($BNTX), 10.996% mit Pfizer ($PFE), 31.205% mit Amgen ($AMG) und 134.452% mit Biogen ($BIIB). Jetzt 217% mit Biotech Aktientip Vidac : https://www.irw-press.at/prcom/images/messages/2023/71224/AC_VidacPharma_050723.001.png](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBNzVEYXc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--e681713d74d225c9ff5e1cb9ac83ef3ff82c2797/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/AC_VidacPharma_050723.001.png?locale=de)
Eilt: Erstklassige Studienergebnisse im Kampf gegen Hautkrebs. Neuer 217% Biotech Hot Stock nach 3.296% mit BioNTech ($BNTX), 10.996% mit Pfizer ($PFE), 31.205% mit Amgen ($AMG) und 134.452% mit Biogen ($BIIB). Jetzt 217% mit Biotech Aktientip Vidac
Eilt: Erstklassige Studienergebnisse im Kampf gegen Hautkrebs. Neuer 217% Biotech Hot Stock nach 134.452% mit Biogen
05.07.23 08:17
London (www.aktiencheck.de, Anzeige)
![Eilt: Sensationelle Studienergebnisse - Massives Kaufsignal. Neuer 224% Biotech Aktientip nach 3.296% mit BioNTech ($BNTX), 10.996% mit Pfizer ($PFE), 31.205% mit Amgen ($AMG) und 134.452% mit Biogen ($BIIB): https://www.irw-press.at/prcom/images/messages/2023/71203/Acresearch040723_01.001.png](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBM1pEYXc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--9cf6ff849545ee031a7c43df64ea5ff8aadf9f90/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/Acresearch040723_01.001.png?locale=de)
Eilt: Sensationelle Studienergebnisse - Massives Kaufsignal. Neuer 224% Biotech Aktientip nach 3.296% mit BioNTech ($BNTX), 10.996% mit Pfizer ($PFE), 31.205% mit Amgen ($AMG) und 134.452% mit Biogen ($BIIB)
Eilt: Sensationelle Studienergebnisse - Massives Kaufsignal. Neuer 224% Biotech Aktientip nach 31.205% mit Amgen ($AMGN)
04.07.23
London (www.aktiencheck.de, Anzeige)
![Eilt: Sensationelle Studienergebnisse - Massives Kaufsignal. Neuer 224% Biotech Aktientip nach 3.296% mit BioNTech ($BNTX), 10.996% mit Pfizer ($PFE), 31.205% mit Amgen ($AMG) und 134.452% mit Biogen ($BIIB): https://www.irw-press.at/prcom/images/messages/2023/71203/Acresearch040723_01.001.png](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBM1pEYXc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--9cf6ff849545ee031a7c43df64ea5ff8aadf9f90/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/Acresearch040723_01.001.png?locale=de)
Eilt: Sensationelle Studienergebnisse - Massives Kaufsignal. Neuer 224% Biotech Aktientip nach 3.296% mit BioNTech ($BNTX), 10.996% mit Pfizer ($PFE), 31.205% mit Amgen ($AMG) und 134.452% mit Biogen ($BIIB)
Eilt: Sensationelle Studienergebnisse - Massives Kaufsignal. Neuer 224% Biotech Aktientip nach 31.205% mit Amgen ($AMGN)
04.07.23
London (www.aktiencheck.de, Anzeige)
![Eilt: Sensationelle Studienergebnisse - Massives Kaufsignal. Neuer 224% Biotech Aktientip nach 3.296% mit BioNTech ($BNTX), 10.996% mit Pfizer ($PFE), 31.205% mit Amgen ($AMG) und 134.452% mit Biogen ($BIIB): https://www.irw-press.at/prcom/images/messages/2023/71203/Acresearch040723_01.001.png](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBM1pEYXc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--9cf6ff849545ee031a7c43df64ea5ff8aadf9f90/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/Acresearch040723_01.001.png?locale=de)
Eilt: Sensationelle Studienergebnisse - Massives Kaufsignal. Neuer 224% Biotech Aktientip nach 3.296% mit BioNTech ($BNTX), 10.996% mit Pfizer ($PFE), 31.205% mit Amgen ($AMG) und 134.452% mit Biogen ($BIIB)
Eilt: Sensationelle Studienergebnisse - Massives Kaufsignal. Neuer 224% Biotech Aktientip nach 31.205% mit Amgen ($AMGN)
04.07.23
London (www.aktiencheck.de, Anzeige)
![Tesla Production Cranks Into High Gear, Shares Follow: https://www.marketbeat.com/logos/articles/med_20230703093828_chart-tsla-732023.png](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBeXREYXc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--30f2c5b5451fc6bf6b02c87b30399cbbca983f16/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/med_20230703093828_chart-tsla-732023.png?locale=de)
Tesla Production Cranks Into High Gear, Shares Follow
Tesla (NASDAQ: TSLA) was expected to increase production and set a record, but the Q2 results were shocking. The company produced 479,700 vehicles in the quarter and delivered 466,140 compared to
![Tesla Production Cranks Into High Gear, Shares Follow: https://www.marketbeat.com/logos/articles/med_20230703093828_chart-tsla-732023.png](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBeXREYXc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--30f2c5b5451fc6bf6b02c87b30399cbbca983f16/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/med_20230703093828_chart-tsla-732023.png?locale=de)
Tesla Production Cranks Into High Gear, Shares Follow
Tesla (NASDAQ: TSLA) was expected to increase production and set a record, but the Q2 results were shocking. The company produced 479,700 vehicles in the quarter and delivered 466,140 compared to
![Ford Soars 30% YTD After Breaking Out: What's Next?: https://www.marketbeat.com/logos/articles/med_20230703085449_ford-soars-30-ytd-after-breaking-out-whats-next.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBeXhEYXc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--30d8790929d07da81ce57399357471e81648a8d8/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/med_20230703085449_ford-soars-30-ytd-after-breaking-out-whats-next.jpg?locale=de)
Ford Soars 30% YTD After Breaking Out: What's Next?
The renowned American automaker Ford Motor Company (NYSE: F)has been making significant progress in the market this year, with its stock up over 30% YTD. Shares of Ford recently broke out of a
![Acuity Brands Lights Up Opportunity In The Industrial Sector: https://www.marketbeat.com/logos/articles/med_20230703083947_chart-ayi-732023.png](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBeTFEYXc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--bd99bad6e7cde9d1b91eaa6e76d626bab8652b73/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/med_20230703083947_chart-ayi-732023.png?locale=de)
Acuity Brands Lights Up Opportunity In The Industrial Sector
Acuity Brands (NYSE: AYI) helped light up an opportunity in the industrial sector when it reported earnings in late June. The industrial sector is 1 of only 5 sectors expected to report earnings
![Overstock Looks Beyond Overbought After Bed Bath Re-Brand: https://www.marketbeat.com/logos/articles/med_20230703082521_overstock-looks-beyond-overbought-after-bed-bath-r.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBeVZEYXc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--19757c62a26b558c4c2e94b3b23af25b4c83176d/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/med_20230703082521_overstock-looks-beyond-overbought-after-bed-bath-r.jpg?locale=de)
Overstock Looks Beyond Overbought After Bed Bath Re-Brand
What do online home furnisher Overstock.com, Inc. (NASDAQ:OSTK) and clothing retailer Burlington Stores have in common? Both are turning to the bankrupt Bed Bath & Beyond to generate inexpensive
![Pure Storage is Pure Gold for Customers and Investors: https://www.marketbeat.com/logos/articles/med_20230702163914_chart-pstg2.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBL05DYXc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--73c46d76dd7a10425145d75c8feb8ad83f9ef69f/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/med_20230702163914_chart-pstg2.jpg?locale=de)
Pure Storage is Pure Gold for Customers and Investors
Enterprise data storage solutions provider Pure Storage Inc. (NYSE: PSTG) stock has traded in a weekly rectangle trading range for over a year as shares attempt another breakout at the upper